Navigating the Clinical Research Process for Mild Cognitive Impairment - Trial NCT06207903
Access comprehensive clinical trial information for NCT06207903 through Pure Global AI's free database. This phase not specified trial is sponsored by Power Life Sciences Inc. and is currently Not yet recruiting. The study focuses on Mild Cognitive Impairment. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Power Life Sciences Inc.
Timeline & Enrollment
N/A
Feb 01, 2025
Feb 01, 2027
Primary Outcome
Rate of patients who decide to enroll in a mild cognitive impairment clinical research.,Number of mild cognitive impairment study participants who remain in clinical study until completion.
Summary
Participation in medical research usually favors a particular demographic group. But there is
 limited research available to explain what trial attributes affect the completion of these
 specific demographic groups.
 
 This trial will admit a wide range of data on the clinical trial experience of mild cognitive
 impairment patients to determine which factors prevail in limiting a patient's ability to
 join or finish a trial.
 
 It will also try to analyze data from the perspective of different demographic groups to
 check for recurring trends which might yield insights for the sake of future mild cognitive
 impairment patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06207903
Non-Device Trial